Skip to main content
. Author manuscript; available in PMC: 2020 Nov 9.
Published in final edited form as: Lab Invest. 2018 Jan 18;98(5):620–628. doi: 10.1038/s41374-017-0013-4

Figure 5. Anti-CXCR3 treatment leads to enhanced autoantibody production.

Figure 5.

Anti-CXCR3 antibody or IgG was i.p.-administered to 4-week-old female NOD mice 3 times weekly for 6 weeks. (A) Detection of serum ANA. Original magnification: ×400. Bar graph shows the fluorescence intensity of ANA staining. (B) Analyses of serum anti-M3R autoantibody level by ELISA. Data are representative or the average of analyses of 12–15 mice for each group.